Tochi M Okwuosa DO FACC, FAHA
Echocardiography, Preventive Cardiology
Professor of Medicine and Cardiology, Director of Cardio-Oncology Services, Rush University Medical Center Co-Founder and Founding Chair, Chicago Cardio-Oncology Consortium (CCC) for the Chicago Citywide Cardio-Oncology Rounds (CCCR)
Join to view full profile
800 Rose StLexington, KY 40536
Phone+1 859-323-0295
Fax+1 312-942-5829
Dr. Okwuosa is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Okwuosa is an associate professor and director of the Cardio-Oncology program at Rush University Medical Center. Her research interests focus on preventive cardio-oncology and she is well published and has mentored many trainees in this field. She currently serves as the chair of the cardio-oncology committee within the American Heart Association, sits of various regional and national cardiology/cardio-oncology committees and boards, and is recognized for her pivotal role in creating various successful loco-regional and national cardio-oncology educational and collaborative initiatives.
Education & Training
University of ChicagoFellowship, Cardiovascular Disease, 2006 - 2009- University of ChicagoResidency, Internal Medicine, 2003 - 2006
Philadelphia College of Osteopathic MedicineClass of 2003
Rutgers UniversityB.A., Biology, Summa Cum Laude, 1997 - 1999
University of NigeriaB.Sc., Biochemistry, Minor in Microbiology, 1992 - 1997
Certifications & Licensure
IL State License 2014 - 2029
KY State License 2026 - 2027
MI State License 2011 - 2014
American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- Teaching Faculty of the Year Rush University Internal Medicine, 2021
- Leadership Development Committee American Heart Association Chicago Metro Board, 2019
- The most talked about articles of 2019 JACC: CardioOncology Journal, 2019
Clinical Trials
Publications & Presentations
PubMed
- SGLT2 inhibitors and cardiovascular outcomes in patients with diabetes following hematopoietic stem cell transplantation: A propensity-matched cohort study.Yong Hao Yeo, Hermon Kha Kin Wong, Jia Yi Tan, Tze Ern Ong, Aravinthan Vignarajah
International Journal of Cardiology. 2026-10-15 - Identifying patients at risk of Takotsubo syndrome during cancer treatment: a sex-based cardio-oncology review.Nicole Tesoro, Jennifer Marsidi, Jonathan Spaan, Henry Okoroike, Joanne Sutter
Expert Review of Cardiovascular Therapy. 2026-08-05 - 1 citationsSex Differences in Cancer and Cardiotoxicity: Mechanisms, Outcomes, and Clinical Implications Across Solid and Hematological Malignancies.Kalliopi Keramida, Marianne C Aznar, Jutta Bergler-Klein, Giuseppe Boriani, Daniela Cardinale
Cancers. 2026-05-22
Journal Articles
- The Present and Future Cardiovascular Medicine and Society the Cardiologist and the Cancer Patient: Challenges to Cardio-Oncology (Or Onco-Cardiology) and Call to ActionAgne Paner, Hena Patel, Timothy Kuzel, Parameswaran Venugopal, Tochi M Okwuosa, Nicole Prabhu, Kim A Williams, ScienceDirect
- The Cardiologist and the Cancer PatientTochi Okwuosa, DO, JACC: Cardiovascular Imaging
- Long-Term Change in Alcohol Consumption Status and Variations in Serum Fibrinogen Levels: The Coronary Artery Risk Development in Young Adults (CARDIA) StudyOkwuosa TM, Klein O, Chan C, Schreiner P, Liu K, Green D, BMJ Open, 7/11/2013
Authored Content
- What's Old Is New: Patients Want Good New Days in Health CareFebruary 2020
- The Cardiologist and the Cancer PatientJuly 2018
Press Mentions
Advanced CKM Syndrome Associated with Greater Cancer RiskMay 5th, 2026- Chicago Heart Expert Breaks down New Study Linking Melatonin Use to Heart RisksNovember 5th, 2025
- New Melatonin Study Raises Heart Health Concerns — What Doctors Say You Should Know | ChicagoLIVENovember 4th, 2025
Grant Support
- The Role of suPAR in Doxorubicin Induced Cardiomyopathy in Breast Cancer Patients: Causative vs. PredictorBrian Piccolo Cancer Research Fund/Gavers Community Cancer Foundation2016–2018
Professional Memberships
- Fellow
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
